We’re glad to see you’re enjoying ReachMD…but how about a more personalized experience?
HER2+ Advanced Solid Tumors: A Fireside Chat on Harnessing Molecular Profiling to Improve Patient Outcomes
December 08, 2024
Singapore
Chairperson's Perspective: Redefining Treatment Across the Spectrum of HR+/HER2-Expressing Metastatic Breast Cancer
Sara M. Tolaney, MD, MPH
Improving Outcomes and Addressing Racial Disparities in Patients With HR+/HER2- Early Breast Cancer: A Case-Based Learning Lab
ADCs in Gynecologic Cancers: Managing Pulmonary and Cardiac TEAEs
Susana Campos, MD, MPH
Managing Pulmonary and Cardiac Adverse Events Related to ADC Therapy in Breast Cancer
Nadia Harbeck, MD, PhD
Managing ADC-Related Pulmonary and Cardiac AEs in NSCLC
Egbert Smit, MD
Mastering the AEs of ADCs to Unlock Their Full Potential in Breast, Lung, and Gynecologic Cancer
Gastrointestinal and Hematologic TEAEs Related to ADC Therapy in Gynecologic Cancers
Emerging ADC Therapies for NSCLC: Anticipating AEs Reported in Clinical Trials
Optimal Management of ADC-Related Gastrointestinal AEs in NSCLC
ADC-Related Hematologic Adverse Events
ADCs on the Horizon for Breast Cancer: Managing Treatment-Emergent Toxicities
Risk Reduction and Management Protocols for Gastrointestinal Adverse Events With ADC Therapy in Breast Cancer
Hematologic Adverse Events With ADCs in Breast Cancer: Optimal Management Strategies
KOL Knockout™: Cancer Pain Management Edition
Pranshu Mohindra, MD
Melissa Teply, MD
Judith Paice, PhD, RN
Fionnuala Crowley, MD
Press cancel to remain on ReachMD. Press the link below or the continue button to keep going.
Stay current with the best on medical education